NEW ENGLAND OPHTHALMOLOGICAL SOCIETY INC (EIN 222852977) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1984

Legal Domicile

Principal Officer

BRENDAN MCCARTHY MD PRESIDENT

Phone

7814347656

Tax Period

2022-07-01 to 2023-06-30

NEW ENGLAND OPHTHALMOLOGICAL SOCIETY INC, founded in 1984, is a small nonprofit that reported $525K in total revenue in fiscal year 2022. Revenue fell 29% from the prior year — a significant decline worth monitoring. Expenses of $594K exceeded revenue, resulting in a 13% operating deficit.

Mission

THE NEW ENGLAND OPHTHALMOLOGICAL SOCIETY, INC. SEEKS TO PROMOTE INTEREST IN THE STUDY AND ADVANCEMENT OF OPHTHALMOLOGY THROUGH EDUCATIONAL SEMINARS AND INFORMATION FOR PROFESSIONALS AND PUBLIC

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $10,050

Program Service Revenue $462,684

Investment Income $52,301

Other Revenue $0

TOTAL REVENUE $525,035

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $466,014

Other Expenses $593,777

TOTAL EXPENSES $593,777

Year-over-Year Comparison

	2022	2021	Change
Revenue	$525,035	$734,747	-0.3%
Expenses	$593,777	$519,308	+0.1%
Net Income	$-68,742	$215,439	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRENDAN MCCARTHY MD	PRESIDENT	4.00	Officer Director	$0	$0	$0
MARY DALYMD	PAST PRESIDENT	4.00	Director	$0	$0	$0
JOHN DAGIANIS MD	INCOMING TREASURER/PAST PRESIDENT	4.00	Director	$0	$0	$0
CLAUDIA RICHTER MD	PRESIDENT ELECT	4.00	Director	$0	$0	$0
JOSEPH RIZZO MD	OUTGOING TREASURER	4.00	Officer Director	$0	$0	$0
JORGE ARROYO MD MPH	PAST PRESIDENT/NOMINATIONS/POLICIES	4.00	Director	$0	$0	$0
NINANI KOMBO MD	SECRETARY	4.00	Officer Director	$0	$0	$0
ANGELA TURALBA MD	DIRECTOR OF CME	4.00	Director	$0	$0	$0
MICHAEL BRADBURY MD	EXECUTIVE DIRECTOR	4.00	Director	$0	$0	$0
MARK LEIBOLE MD	CHAIR - OPHTHALMIC SERVICES	4.00	Director	$0	$0	$0
MICHELLE LIANG MD	IT COMMITTEE CHAIR	4.00	Director	$0	$0	$0
FINA BAROUCH MD	CHAIR - PROGRAM COMMITTEE	4.00	Director	$0	$0	$0
ANITA SHUKLA MD	YOUNG OPHTHALMOLOGISTS COMM	4.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$525,035	$593,777	$2,666,811	$-68,742
2022	$734,747	$519,308	$2,548,920	$215,439
2021	$484,356	$256,544	$2,659,333	$227,812
2020	$1,171,848	$373,639	$2,142,680	$798,209
2019	$749,282	$623,560	$1,348,563	$125,722
2018	$663,444	$627,666	$1,278,819	$35,778

NEW ENGLAND OPHTHALMOLOGICAL SOCIETY INC